Related Experiment Videos
Neopterin in acute pancreatitis
Scandinavian Journal of Gastroenterology
|October 1, 1996
Summary
Serum neopterin and IL-6 levels indicate acute pancreatitis (AP) severity. Higher neopterin in severe AP patients suggests it is a reliable prognostic indicator, especially during the first week.
Area of Science:
- Immunology
- Gastroenterology
- Biomarker Research
Background:
- Cellular immune system activation is implicated in acute pancreatitis (AP) pathogenesis.
- Excessive leukocyte stimulation may correlate with severe AP.
- Investigating serum neopterin as a macrophage activation marker in AP is crucial.
Purpose of the Study:
- To investigate serum neopterin levels in mild and severe AP.
- To assess the relationship between neopterin, IL-6, and TNF in AP.
- To evaluate neopterin as a prognostic indicator for AP severity.
Main Methods:
- Serum neopterin, IL-6, and TNF levels were measured in 17 severe AP and 24 mild AP patients on days 1 and 7.
- Severe AP was defined by Atlanta criteria and CT scan findings.
- Normal controls were included for comparison.
Main Results:
- On Day 1, neopterin and IL-6 were significantly higher in severe AP than mild AP and controls.
- Neopterin levels increased from Day 1 to Day 7 in severe AP patients only.
- A neopterin cutoff of 40 mmol/ml showed 92% specificity and sensitivity for differentiating severe from mild AP.
Conclusions:
- Cellular immune system activation is confirmed in AP.
- Elevated neopterin and IL-6 levels correlate with AP severity.
- Neopterin serves as a reliable prognostic indicator for AP, particularly in severe cases.